Evidence map›Paper›PMID 40127955›Full record

ArticleGenes & development2025

MRN-CtIP, EXO1, and DNA2-WRN/BLM act bidirectionally to process DNA gaps in PARPi-treated cells without strand cleavage.

Isabelle M Seppa, Ilaria Ceppi, Mithila Tennakoon, Giordano Reginato, Jessica Jackson, Celia D Rouault, Sumedha Agashe, Vladislav O Sviderskiy, Mangsi Limbu, Erica Lantelme and 6 more

Abstract read
In one paragraph

Article in Genes & development, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Isabelle M Seppa *Division of Oncology, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri 63110, USA.
Ilaria Ceppi *Institute for Research in Biomedicine (IRB), Università della Svizzera italiana, CH 6500 Bellinzona, Switzerland.
Mithila TennakoonDivision of Oncology, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri 63110, USA.
Giordano ReginatoInstitute for Research in Biomedicine (IRB), Università della Svizzera italiana, CH 6500 Bellinzona, Switzerland.
Jessica JacksonDivision of Oncology, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri 63110, USA.
Celia D RouaultDivision of Oncology, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri 63110, USA.
Sumedha AgasheDivision of Oncology, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri 63110, USA.
Vladislav O SviderskiyDivision of Oncology, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri 63110, USA.
Mangsi LimbuDivision of Oncology, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri 63110, USA.
Erica LantelmeDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Alice MeroniDivision of Oncology, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri 63110, USA.
Stefan BraunshierInstitute for Research in Biomedicine (IRB), Università della Svizzera italiana, CH 6500 Bellinzona, Switzerland.
Damiano BorrelloInstitute for Research in Biomedicine (IRB), Università della Svizzera italiana, CH 6500 Bellinzona, Switzerland.
Priyanka VermaDivision of Oncology, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri 63110, USA.
Petr CejkaInstitute for Research in Biomedicine (IRB), Università della Svizzera italiana, CH 6500 Bellinzona, Switzerland.
Alessandro VindigniDivision of Oncology, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri 63110, USA; avindigni@wustl.edu.ORCID 0000-0002-0568-5067

Funding

Mechanisms of replication fork protection and recoveryR01CA248526 · NCI · WASHINGTON UNIVERSITY · PI Alessandro Vindigni, Lee Zou · 2020 to 2026
$3.6M
Replication fork repriming versus reversalR01CA237263 · NCI · WASHINGTON UNIVERSITY · PI Alessandro Vindigni · 2019 to 2026
$3.0M
NCI NIH HHS R01 CA237263NCI NIH HHS R01 CA248526
6 · The paper itself

Abstract

Single-stranded DNA (ssDNA) gaps impact genome stability and PARP inhibitor (PARPi) sensitivity, especially in BRCA1/2-deficient tumors. Using single-molecule DNA fiber analysis, electron microscopy, and biochemical methods, we found that MRN, CtIP, EXO1, and DNA2-WRN/BLM resect ssDNA gaps through a mechanism different from their actions at DNA ends. MRN resects ssDNA gaps in the 3'-to-5' direction using its pCtIP-stimulated exonuclease activity. Unlike at DNA ends, MRN does not use its endonucleolytic activity to cleave the 5'-terminated strand flanking the gap or the ssDNA. EXO1 and DNA2-WRN/BLM specifically resect the 5' end of the gap independent of MRN-CtIP. This resection process alters ssDNA gap repair kinetics in BRCA1-proficient and -deficient cells. In BRCA1-deficient cells treated with PARPis, excessive resection results in larger ssDNA gaps, hindering their repair and leading to DNA breaks in subsequent cell cycle stages due to ssDNA gaps colliding with DNA replication forks. These findings broaden our understanding of the role of human nucleases in DNA metabolism and have significant implications for defining the mechanisms driving PARPi sensitivity in BRCA-deficient tumors.

Indexed as

DNA HelicasesDNA Repair EnzymesExodeoxyribonucleasesNuclear ProteinsPoly(ADP-ribose) Polymerase InhibitorsBRCA1 ProteinDNA-Binding ProteinsDNA RepairDNA, Single-StrandedEndodeoxyribonucleasesHumansRecQ HelicasesBRCA1 ProteinDNA2 protein, humanDNA-Binding ProteinsDNA HelicasesDNA Repair EnzymesDNA, Single-StrandedEndodeoxyribonucleasesEXO1 protein, humanexodeoxyribonuclease IExodeoxyribonucleasesNuclear ProteinsPoly(ADP-ribose) Polymerase InhibitorsRBBP8 protein, humanRecQ HelicasesBRCADNA replicationDNA replication stressgenome stabilityMRE11nucleasesPARP inhibitorsingle-stranded DNA gaps

Identifiers

PMID40127955
PMCPMC12047661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.